Functional and phenotypic analyses of interleukin 2-activated tumor-infiltrating lymphocytes
- 1 July 1990
- journal article
- case report
- Published by Springer Nature in Biotherapy
- Vol. 2 (3) , 247-259
- https://doi.org/10.1007/bf02173526
Abstract
The tumor-infiltrating lymphocytes (TILs) were cultured with interleukin 2 (IL-2) to induce the activated killer cells possessing autologous tumor-killing activity, and analysed their cell surface phenotypes and assessed anti-tumor killing activity. Furthermore, the activated TILs were transferred into 7 patients adoptively resulting in complete remission in a patient with pancreatic cancer and partial remission in another patient with gastric cancer. The cytotoxic activities of activated TILs at 3 weeks-incubation was 72 ± 15, 42 ± 26, 27 ± 21 and 25 ± 15% against K562, Daudi, KATO-III and autologous tumor, respectively. The negative selection method, indicated that the killer cells recognizing autologous tumor cells consisted of CD4- or CD8-positive T lymphocytes and CD16- or CD56-positive natural killer cells. The activated TILs could not only lyse cultured tumor cell lines, but also autologous tumor cells.Keywords
This publication has 31 references indexed in Scilit:
- Augmentation of Human Cytotoxic T Lymphocytes against Autologous Tumor by a Factor Released from Human Monocytic Leukemia Cell LineJapanese Journal of Cancer Research, 1989
- Properties of recombinant interleukin 2-cultured tumor-infiltrating lymphocytes in human lung cancerInternational Journal of Cancer, 1989
- Tumor‐specific T Cells which Form Clusters with Dendritic Cells and Tumor Cells and Deliver Macrophage‐activating FactorsJapanese Journal of Cancer Research, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.The Journal of Experimental Medicine, 1984
- Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cellsCancer, 1984
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982